Home-based Assessment of Medication Understanding and Use in People With Multiple Sclerosis
Study explores how people with MS manage their medications at home
Plain English Summary
Medication Understanding in MS is a Not Applicable clinical trial sponsored by University of Nottingham studying Multiple Sclerosis. This study observes how individuals with Multiple Sclerosis (MS) understand, organize, and use their medications at home. It is for adults aged 18 and over with a confirmed diagnosis of MS who live in the community. Participation involves a single home visit where researchers will review all medications and supplements, discuss routines and challenges, and ask brief questions about memory. No new treatments are being tested; this is an observational study to understand current medication practices. The trial aims to enroll 80 participants.
Official Summary
The goal of this observational study is to learn how people with multiple sclerosis (MS) understand, organise, and use their medicines at home. The study aims to explore how people take their prescribed and non-prescribed medicines, what challenges they experience, and whether any safety issues arise in day-to-day medication use. Participants will take part in one home visit with trained student researchers. During the visit, researchers will review all medicines and supplements the participant uses, ask about routines and any difficulties, check medication packaging with permission, and ask a brief question about memory. No treatment changes will be made. Information will be reviewed by a senior clinician, and any safety concerns will be shared with the participant's usual healthcare team.
Who Can Participate
Here is what you need to know about eligibility for this trial. You can join if you are 18 or older, have MS, live at home, and take at least one prescription medication. You cannot join if you have severe cognitive or communication problems without a helper, if a home visit is unsafe, or if you do not speak English. You must be able to give permission to participate or have someone who can give permission on your behalf. This trial is studying Multiple Sclerosis, so participants generally need a confirmed diagnosis.
What They're Measuring
The primary outcome measures how burdensome medication management is for patients, aiming to identify ways to make it easier and safer. The specific primary outcome measures are: Medication Burden (Descriptive) (Baseline). These endpoints are how researchers determine whether the treatment is effective and will form the basis of any future regulatory submissions.
About This Phase
This study does not have a traditional clinical phase designation. It may be an observational study that follows patients without intervening in their care, an expanded access or compassionate use program, or other non-interventional research. These studies contribute valuable data about disease progression, treatment patterns, and patient outcomes.
Why This Trial Matters
This trial matters because understanding how people with MS manage their medications at home can help improve support and reduce potential safety issues, filling a gap in current patient care. This research targets Multiple Sclerosis, where improved treatment options are needed.
Investor Insight
This observational study by a university sponsor suggests a focus on patient support and adherence in MS, a large and growing market, with potential implications for future adherence-focused digital h
Is This Trial Right for Me?
Ask your doctor about how to best manage your medications and if there are any specific resources available for MS patients. Be prepared to discuss all the medications and supplements you take, including over-the-counter ones and vitamins. The home visit will involve talking about your daily routines related to taking medicine and any difficulties you face. The trial is being conducted at multiple sites. Always discuss clinical trial participation with your healthcare provider before making any decisions. This information is for educational purposes only and is not medical advice.
AI-generated analysis for educational purposes only. This is not medical advice. Discuss clinical trial participation with your doctor. Data sourced from ClinicalTrials.gov.
Study Design
- Study Type: OBSERVATIONAL
- Enrollment: 80 participants
Primary Outcomes
- Medication Burden (Descriptive) (Baseline)
Secondary Outcomes
- Medication Adherence (MARS-5 Score) (Baseline)
- Medication-Related Challenges (Baseline)
- Subjective Cognitive Decline (Single-Item Question) (Baseline)
- Medication Organisation and Use of Aids (Baseline)
- Medication Storage and Safety Issues (Baseline)
Full Eligibility Criteria
Inclusion Criteria: * Adults aged 18 years and over with a confirmed diagnosis of multiple sclerosis * Living in the community (not in residential care) * Taking at least one prescribed medication * Able to provide informed consent or, for those without capacity to provide informed consent, with a consultee available to provide consultee declaration and provide information during home-based medication review * Willing and able to participate in a home-based medication review Exclusion Criteria: * Severe cognitive or communication impairment without a consultee to provide consultee declaration and medication-related information * Participants for whom a home visit is deemed unsafe * Non-English speakers
Frequently Asked Questions
What is clinical trial NCT07518381?
NCT07518381 is a Not Applicable OBSERVATIONAL study titled "Medication Understanding in MS." It is currently not yet recruiting and is sponsored by University of Nottingham. The trial targets enrollment of 80 participants.
What conditions does NCT07518381 study?
This trial investigates treatments for Multiple Sclerosis. The primary condition under study is Multiple Sclerosis.
What does Not Applicable mean for NCT07518381?
This study does not have a defined clinical phase. It may be an observational study, expanded access program, or other non-interventional research.
What is the current status of NCT07518381?
This trial is currently "Not Yet Recruiting." It started on 2026-04-15. The estimated completion date is 2026-09-01.
Who is sponsoring NCT07518381?
NCT07518381 is sponsored by University of Nottingham. The sponsor is responsible for funding, designing, and overseeing the clinical trial.
How many people can participate in NCT07518381?
The trial aims to enroll 80 participants. The trial has not yet started recruiting.
How is NCT07518381 designed?
This is a observational study.
What are the primary outcomes being measured in NCT07518381?
The primary outcome measures are: Medication Burden (Descriptive) (Baseline). These are the main endpoints researchers use to determine whether the treatment is effective.
Where can I find official information about NCT07518381?
The official record for NCT07518381 is available on ClinicalTrials.gov at https://clinicaltrials.gov/study/NCT07518381. This government database provides the most up-to-date and detailed information about the trial.
What is NCT07518381 testing in simple terms?
This study observes how individuals with Multiple Sclerosis (MS) understand, organize, and use their medications at home. It is for adults aged 18 and over with a confirmed diagnosis of MS who live in the community.
Why is this trial significant?
This trial matters because understanding how people with MS manage their medications at home can help improve support and reduce potential safety issues, filling a gap in current patient care.
What are the potential risks of participating in NCT07518381?
The main risk is the potential for discomfort discussing personal medication habits. No treatment changes will be made, so risks associated with new medications are not applicable. Any safety concerns identified during the review will be shared with your healthcare team. As with any clinical trial, participants are closely monitored and can withdraw at any time.
Should I consider participating in NCT07518381?
Ask your doctor about how to best manage your medications and if there are any specific resources available for MS patients. Be prepared to discuss all the medications and supplements you take, including over-the-counter ones and vitamins. The home visit will involve talking about your daily routines related to taking medicine and any difficulties you face. Always discuss clinical trial participation with your healthcare provider to determine if it is appropriate for your specific situation.
What does NCT07518381 signal from an investment perspective?
This observational study by a university sponsor suggests a focus on patient support and adherence in MS, a large and growing market, with potential implications for future adherence-focused digital h This is a Not Applicable trial, which is in early development stages.
What happens if the treatment in this trial doesn't work?
Participation involves a single home visit where researchers will review all medications and supplements, discuss routines and challenges, and ask brief questions about memory. Participants in clinical trials always have the right to withdraw and pursue alternative treatments. The study team will help transition patients to other available options.
Related Conditions
More Multiple Sclerosis Trials
This analysis is AI-generated and does not constitute medical advice. Always consult your healthcare provider before making decisions about clinical trial participation.